In Brief
Is the proposed IP waiver to help combat Covid-19 all it seems?
Will the Delta variant, currently ripping its way across the world, and the many other unknowns in relation to Covid-19 now justify the ‘exceptional circumstances’ needed for a waiver of certain intellectual property (IP) rights under the TRIPS Agreement? Well, this will probably not be necessary, even in the current circumstances. The argument for an […]